ORIAU

Orion Biotech Opportunities Corp. Units

Delisted

ORIAU was delisted on the 25th of April, 2023.

21 hedge funds and large institutions have $73.8M invested in Orion Biotech Opportunities Corp. Units in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-22
Holders Change %
-51.16%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
4
Reduced
7
Closed
23
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
ACM
26
Atalaya Capital Management
New York
-$5.03M -500,000 Closed
FIG
27
Fortress Investment Group
New York
-$4.31M -428,902 Closed
RCM
28
Radcliffe Capital Management
Pennsylvania
-$4.02M -400,000 Closed
AGC
29
Angelo Gordon & Co
New York
-$3.02M -300,000 Closed
Marshall Wace
30
Marshall Wace
United Kingdom
-$2.78M -275,000 Closed
UOC
31
UBS O'Connor
Illinois
-$2.53M -250,000 Closed
AA
32
AQR Arbitrage
Connecticut
-$2.02M -200,000 Closed
RCM
33
Rivernorth Capital Management
Florida
-$1.76M -175,000 Closed
DCM
34
DG Capital Management
New York
-$1.77M -175,000 Closed
WRBC
35
W.R. Berkley Corp
Connecticut
-$1.74M -173,095 Closed
PMAM
36
Picton Mahoney Asset Management
Ontario, Canada
-$1.51M -150,000 Closed
SCM
37
Segantii Capital Management
Hong Kong
-$1.52M -150,000 Closed
CH
38
CVI Holdings
Delaware
-$1.01M -100,000 Closed
DCM
39
Dupont Capital Management
Delaware
-$1.01M -100,000 Closed
AFM
40
Anson Funds Management
Texas
-$754K -75,000 Closed
WA
41
Whitebox Advisors
Minnesota
-$754K -75,000 Closed
EAM
42
Exos Asset Management
New York
-$562K -55,685 Closed
PAM
43
Panagora Asset Management
Massachusetts
-$136K -13,491 Closed
GT
44
Glenmede Trust
Pennsylvania
-$120K -11,956 Closed